BR112014015178A2 - uso de pelo menos um composto - Google Patents
uso de pelo menos um compostoInfo
- Publication number
- BR112014015178A2 BR112014015178A2 BR112014015178A BR112014015178A BR112014015178A2 BR 112014015178 A2 BR112014015178 A2 BR 112014015178A2 BR 112014015178 A BR112014015178 A BR 112014015178A BR 112014015178 A BR112014015178 A BR 112014015178A BR 112014015178 A2 BR112014015178 A2 BR 112014015178A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161578650P | 2011-12-21 | 2011-12-21 | |
PCT/US2012/070568 WO2013096423A1 (en) | 2011-12-21 | 2012-12-19 | Combination therapy with interferon and andrographolides for multiple sclerosis |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112014015178A2 true BR112014015178A2 (pt) | 2017-06-13 |
Family
ID=48669439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014015178A BR112014015178A2 (pt) | 2011-12-21 | 2012-12-19 | uso de pelo menos um composto |
Country Status (10)
Country | Link |
---|---|
US (1) | US9060994B2 (pt) |
EP (1) | EP2670406B1 (pt) |
JP (1) | JP5936707B2 (pt) |
AU (1) | AU2012359081B2 (pt) |
BR (1) | BR112014015178A2 (pt) |
CA (1) | CA2853779C (pt) |
CL (1) | CL2014001663A1 (pt) |
ES (1) | ES2554459T3 (pt) |
RU (1) | RU2014113967A (pt) |
WO (1) | WO2013096423A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK3468553T3 (da) * | 2016-06-08 | 2023-07-03 | Innobioscience Llc | Andrographolid behandler progressive former for multipel sklerose |
US11318153B2 (en) | 2018-06-25 | 2022-05-03 | Bialpha International Sdn. Bhd. | Method of using Neoandrographolide for lowering blood sugar, lowering blood lipid, improving liver function and improving renal function |
CN109824655B (zh) * | 2019-04-08 | 2021-09-24 | 沈阳药科大学 | 穿心莲内酯化合物及其制备方法和用途 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1043027A1 (en) * | 1999-04-08 | 2000-10-11 | Applied Research Systems ARS Holding N.V. | Treatment of multiple sclerosis with a combination of Interferon and Growth hormone |
US6410590B1 (en) | 2000-02-03 | 2002-06-25 | Dr. Reddy's Research Foundation | Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them |
US20050181033A1 (en) * | 2000-06-29 | 2005-08-18 | Dekker John P.Iii | Method for delivering interferons to the intradermal compartment |
US20030082138A1 (en) | 2001-09-18 | 2003-05-01 | Chiron Corporation | Methods for treating multiple sclerosis |
CN1921872A (zh) * | 2004-02-03 | 2007-02-28 | 智利南方大学 | 用于激活PPR-γ受体而治疗自身免疫性疾病和阿尔茨海默病的提取自穿心莲的半日花烷型二萜类组合物 |
US20050220764A1 (en) | 2004-04-01 | 2005-10-06 | Schering Aktiengesellschaft | Higher-doses of interferon-beta for treatment of multiple sclerosis |
US20080108641A1 (en) | 2006-02-08 | 2008-05-08 | Ajami Alfred M | Compounds for treating inflammatory disorders, demyelinating disdorders and cancers |
US8741950B2 (en) * | 2009-06-22 | 2014-06-03 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating or preventing fatigue |
-
2012
- 2012-12-19 US US13/984,124 patent/US9060994B2/en active Active
- 2012-12-19 JP JP2014548825A patent/JP5936707B2/ja active Active
- 2012-12-19 CA CA2853779A patent/CA2853779C/en active Active
- 2012-12-19 ES ES12859754.9T patent/ES2554459T3/es active Active
- 2012-12-19 WO PCT/US2012/070568 patent/WO2013096423A1/en active Application Filing
- 2012-12-19 EP EP12859754.9A patent/EP2670406B1/en active Active
- 2012-12-19 AU AU2012359081A patent/AU2012359081B2/en active Active
- 2012-12-19 BR BR112014015178A patent/BR112014015178A2/pt not_active Application Discontinuation
- 2012-12-19 RU RU2014113967A patent/RU2014113967A/ru not_active Application Discontinuation
-
2014
- 2014-06-20 CL CL2014001663A patent/CL2014001663A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
US20140301981A1 (en) | 2014-10-09 |
AU2012359081B2 (en) | 2015-09-17 |
JP5936707B2 (ja) | 2016-06-22 |
WO2013096423A1 (en) | 2013-06-27 |
CL2014001663A1 (es) | 2015-02-27 |
AU2012359081A1 (en) | 2014-06-05 |
CA2853779C (en) | 2016-04-26 |
ES2554459T3 (es) | 2015-12-21 |
EP2670406B1 (en) | 2015-09-02 |
CA2853779A1 (en) | 2013-06-27 |
EP2670406A4 (en) | 2014-05-28 |
RU2014113967A (ru) | 2016-02-10 |
EP2670406A1 (en) | 2013-12-11 |
NZ625051A (en) | 2016-07-29 |
US9060994B2 (en) | 2015-06-23 |
JP2015500880A (ja) | 2015-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SMT201700094B (it) | Composto di pirazina carbossammide | |
BR112016003454A2 (pt) | Uso de composto de metil bardoxolona | |
BR112014000260A2 (pt) | composto, e, uso de um composto | |
CO6900145A2 (es) | Compuesto de ciclopropanoamina | |
EP3068517A4 (en) | Compositions of lean nox trap | |
BR112014029530A2 (pt) | compostos, composição farmacêutica e uso de um composto | |
BR112014001255A2 (pt) | composto, uso de um composto, combinação, e, composição farmacêutica | |
BR112014013760A2 (pt) | composto, composição farmacêutica e uso de um composto | |
BR112013022112A2 (pt) | composição | |
BR112013023048A2 (pt) | composto de guanidina | |
BR112013022102A2 (pt) | composição | |
DK2686017T3 (da) | Oftalmisk sammensætning | |
BR112014023200A2 (pt) | uso de uma composição | |
CO6930362A2 (es) | Compuesto heterocíclico y su uso | |
BR112014004395A2 (pt) | composição | |
BR112014012016A2 (pt) | compostos | |
BR112014005669A2 (pt) | composto, composição farmacêutica e uso de um composto | |
CO6930368A2 (es) | Composiciones de yodo-povidona estable | |
BR112014003567A2 (pt) | composto, uso de um composto, e, composição farmacêutica | |
CO6910197A2 (es) | Compuestos novedosos | |
DK2706977T3 (da) | Dispergeringsmidler med biobaserede forbindelser | |
BR112014016635A2 (pt) | composto, composição, e, uso de um composto | |
BR112013029206A2 (pt) | composto, e, uso de um composto | |
BR112014013177A2 (pt) | composto, composição farmacêutica e uso de um composto | |
BR112013033808A2 (pt) | composição |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11N | Dismissal: publication cancelled [chapter 11.14 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] | ||
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] |